Delivery Order SPE2DB20D2014-SPE2DB25FC61T
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on July 29, 2025, for the supply of Veozah 45 mg tablets (30-count) valued at $1,246.98. This firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for supplying pharmaceuticals and medical materials to military healthcare systems worldwide. The contract is non-competitive and represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $17,319.74. This firm fixed-price delivery order, awarded on July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and will be performed at the contractor's...
- This delivery order, awarded July 31, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 30 tablets of Veozah 45 mg with a ceiling value of $1,846.62 and completion date of August 1, 2025. The order represents a competitively awarded, firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on July 24, 2025, carries a ceiling value of approximately $21.1K and is set to reach ultimate completion by July 25, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $3,479.11. This non-set-aside delivery order is scheduled for completion by August 1, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.28 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction under a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veozah 45 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract ceiling value is $6,509.38, with an ultimate completion date of July 31, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $12,719.67 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VEOZAH 45 mg tablets in 30-count packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,593.58 delivery order to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count) under a firm fixed-price contract with an ultimate completion date of July 24, 2025. This non-competitive, non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,496.63 on July 28, 2025, with a completion date of July 29, 2025. This non-set-aside contract procures VEOZAH 45 mg tablets in a 30-count package under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC61TDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,921.89 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count packaging). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be performed at the contractor's Conshohocken facility, with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a major healthcare solutions provider registered in the System for Award Management, AmerisourceBergen demonstrates significant capability in fulfilling federal medical supply requirements through competitive procurement processes, with contract awards ranging from small transactions to substantial orders exceeding $45,000. The delivery order for Veozah represents a routine pharmaceutical supply transaction within the company's established relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/31/25 |